Blau Farmaceutica S.A.
4 clinical trials · Sponsor
◉ Watch Blau Farmaceutica S.A.
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration (NCT05788900) | Blau Farmaceutica S.A. | 2023-06-01 |
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration (NCT05788913) | Blau Farmaceutica S.A. | 2023-06-01 |
| Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens (NCT05704894) | Blau Farmaceutica S.A. | 2023-05-01 |
| Effectiveness and Safety Study of FilgrastineĀ® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy (NCT05790096) | Blau Farmaceutica S.A. | 2023-05-01 |
Track Blau Farmaceutica S.A. automatically
Every clearance here is in the API, with alerts when new ones post.